BLDV
vs
ALNY
BLDV
ALNY
Over the past 12 months, BLDV has outperformed ALNY, delivering a return of +50% compared to the ALNY's +34% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
BLDV
ALNY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc
OTC:BLDV
|
0.0003
USD
|
|||||
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
326.75
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
BLDV, ALNY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Blue Diamond Ventures Inc
Revenue
|
|||||||||||
|
Alnylam Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
BLDV, ALNY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Blue Diamond Ventures Inc
OTC:BLDV
|
|||||||||
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Blue Diamond Ventures Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
BLDV, ALNY
Performance By Year
BLDV, ALNY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|